Video
Appropriate use criteria for PSMA-PET imaging will help guide clinicians
Author(s):
Video Player is loading.
In this video, Hossein Jadvar, MD, PhD, MPH, MBA, FACNM, FSNMMI, discusses what he hopes clinicians and patients take away from the recently released appropriate use criteria for prostate-specific membrane antigen (PSMA) PET imaging in prostate cancer. Jadvar is a professor of urology and radiology in the Keck School of Medicine at the University of Southern California in Los Angeles.
Related Videos
Ian Metzler, MD, on the increasing prevalence of kidney stones in women
How pre-URS tamsulosin use in pediatric patients may reduce repeat procedures
Kelly Stratton, MD, reacts to FDA approval of Gozellix for prostate cancer imaging
An expert discusses patient counseling in wake of FDA’s labeling changes for testosterone
Ekene Enemchukwu, MD, on vaginal estrogen for genitourinary syndrome of menopause
Expert discusses innovations in single-use ureteroscopes for stones
Naeem Bhojani, MD, discusses WATER III data on Aquablation vs enucleation for BPH
Matthew Galsky, MD, reacts to NIAGARA results, durvalumab approval for MIBC
Rana McKay, MD, on persistence and adherence to relugolix for prostate cancer
Timothy Lyon, MD, on recent change to outpatient complications metric in urology rankings
Related Content
